Non-alcoholic steatohepatitis

• Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Pending
  2022-500185-94-01 4 "non-alcoholic steatohepatitis"
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensate … Recruiting
  2024-512895-36-00 5 2024-11-25 "Metabolic Dysfunction-Associated Steatohepatitis (MASH)"
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrho … Recruiting
  2023-505141-48-00 5 2024-03-07 "Fibrosis"
• A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Non-Alcoholic St … Recruiting
  2023-510548-19-00 4 2023-03-02 "Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis"
• A Phase 2a Study of Efinopegdutide in Adults With Compensated Cirrhosis Secondary to Metabolic Dysfunction-Associated Steatohepatitis Recruitment ended
  2024-510923-20-00 4 2024-09-16 "Metabolic Dysfunction-Associated Steatohepatitis"
• A clinical study to assess the efficacy and safety of lanifibranor followed by an active treatment extension in adult patients with non-cirr … Recruitment ended
  2023-508248-23-00 5 2021-11-26 "Non-alcoholic steatohepatitis (NASH)"
• Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Recruitment ended
  2023-506962-30-00 5 2021-03-29 "Non-alcoholic steatohepatitis (NASH)"
• A clinical trial to evaluate the safety and effectiveness of MGL-3196 (resmetirom) in patients with Non-Alcoholic Steatohepatitis (NASH) and … Recruitment ended
  2024-510626-89-00 5 2019-11-18 "Non-Alcoholic Steatohepatitis (NASH)"
• A study to compare two different aramchol formulations in healthy volunteers. Ended
  2023-507445-28-00 3 2024-12-18 "Nonalcoholic fatty liver disease"
• MK-7480 Multiple Ascending Dose Study in Healthy Participants Ended
  2023-508982-34-00 3 2024-02-09
• Effects of extensive Weight loss on Insulin resistance and Lipid-kinetics in people with obesity and fatty liver Disease Ended
  2023-506300-12-00 6 2023-12-18 "Obesity, Non-alcoholic Fatty Liver Disease"
• A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children. Ended
  2023-503595-24-00 1 2023-12-14 "Healthy volunteers (Non-alcoholic steatohepatitis (NASH))"
• A clinical trial to learn how an investigational drug (norucholic acid) is absorbed, distributed, broken down, and removed from the body whe … Ended
  2023-505862-27-00 3 2023-10-10 "Nonalcoholic fatty liver disease (NAFLD)"
• A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic Steatohepatitis Ended
  2022-502647-35-00 4 2023-09-01
• MK-7480 Single Ascending Dose Study in Healthy Participants Ended
  2023-505138-88-00 1 2023-08-03
• A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhoti … Ended
  2023-509704-14-00 4 2023-04-28 "Non-cirrhotic non-alcoholic steatohepatitis with fibrosis"
• Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Expired
  2022-500185-94-00 4 "non-alcoholic steatohepatitis"

Showing 1–17 of 17 trials